Search

Search Constraints

You searched for: Author/Creator Mucci, Lorelei

Search Results

1. A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer. Issue 10 (6th May 2021)

2. Cancer Incidence and Mortality in 260, 000 Nordic Twins With 30, 000 Prospective Cancers. (25th April 2019)

3. CanWalk: a feasibility study with embedded randomised controlled trial pilot of a walking intervention for people with recurrent or metastatic cancer. Issue 2 (15th February 2017)

5. Elevated IL‐8, TNF‐α, and MCP‐1 in men with metastatic prostate cancer starting androgen‐deprivation therapy (ADT) are associated with shorter time to castration‐resistance and overall survival. Issue 8 (26th March 2014)

6. Elevated insulin‐like growth factor binding protein‐1 (IGFBP‐1) in men with metastatic prostate cancer starting androgen deprivation therapy (ADT) is associated with shorter time to castration resistance and overall survival. Issue 3 (16th October 2013)

7. Genetic ablation of FASN attenuates the invasive potential of prostate cancer driven by Pten loss. Issue 3 (11th December 2020)

8. Germline Sequencing DNA Repair Genes in 5545 Men With Aggressive and Nonaggressive Prostate Cancer. (27th August 2020)

9. Germline variation at 8q24 and prostate cancer risk in men of European ancestry. Issue 1 (December 2018)

10. Inherited variation in circadian rhythm genes and risks of prostate cancer and three other cancer sites in combined cancer consortia. Issue 9 (29th July 2017)